ADVFN US – Market Content Editor

Akebia Therapeutics (NASDAQ:AKBA) reported mixed fourth-quarter 2025 results, with revenue surpassing analyst forecasts while earnings per share fell short of expectations, as investors focused on improving commercial momentum and a stronger balance sheet. Shares of the kidney-disease drug developer rose sharply in premarket trading following the release, reflecting optimism around revenue growth and cash position…

Eos Energy Enterprises (NASDAQ:EOSE) reported fourth-quarter and full-year 2025 results marked by rapid revenue expansion, improving operational efficiency and a strengthened balance sheet, as the U.S.-based long-duration energy storage developer targets a transition toward scalable, profitable growth. The company, which manufactures zinc-based battery storage systems domestically, delivered record quarterly revenue and introduced initial guidance for…

Rackspace Technology (NASDAQ:RXT) reported fourth-quarter and full-year 2025 results highlighting improving profitability and a strategic pivot toward enterprise cloud and artificial intelligence services, as the hybrid cloud provider positions itself for renewed growth in 2026. Chief Executive Officer Gajen Kandiah said the latest quarter marked a turning point for the company’s transformation efforts. “Q4 capped…

Akebia Therapeutics (NASDAQ:AKBA) reported fourth-quarter revenue that exceeded market expectations and highlighted encouraging early-year commercial performance for its anemia treatment Vafseo, signaling growing momentum following the drug’s initial launch phase. The biopharmaceutical company posted Q4 revenue of $57.62 million, comfortably ahead of the consensus estimate of $46.09 million. Management pointed to improving adoption trends for…

Arhaus (NASDAQ:ARHS) delivered record financial results for 2025 and announced a special cash dividend, underscoring strong operating performance and a solid balance sheet as the premium home furnishings retailer continues expanding its showroom network. For the full year, net revenue rose 8.5% year over year to $1.379 billion, while gross margin increased to $536 million.…

Vital Farms (NASDAQ:VITL) reported solid fourth-quarter and full-year 2025 results on February 26, 2026, driven by strong revenue growth, operational expansion, and continued investment in supply capacity, while also announcing a new share repurchase program. For fiscal 2025, net revenue increased 25.3% year over year to $759.4 million, while adjusted EBITDA rose to $114 million…

GigaCloud Technology (NASDAQ:GCT) reported record financial results for both the fourth quarter and full year of 2025 on February 26, highlighting strong earnings growth, expanding marketplace activity, and a solid cash position. Fourth-quarter revenue increased 22.7% year over year to $362.7 million, while diluted earnings per share rose 36.8% to $1.04. For the full year,…

Avalon GloboCare Corp. (NASDAQ:ALBT) shares skyrocketed more than 138% in premarket trading Thursday after the company revealed it had been accepted into the Advanced Micro Devices AI Developer Program, a move aimed at accelerating its artificial intelligence development initiatives. Through the program, Avalon will gain access to AMD Developer Cloud credits, specialized development tools, technical…

Thryv Holdings Inc (NASDAQ:THRY) reported strong expansion in its software-as-a-service business for 2025, highlighting continued progress in its transition toward a subscription-based, AI-focused operating model. The company generated SaaS revenue of $461.0 million for the full year, marking a 34.2% increase compared with 2024, according to its latest earnings release. In the fourth quarter alone,…

Wells Fargo reduced its price target on Procept BioRobotics Corp (NASDAQ:PRCT) to $34 from $51 while reiterating its Overweight rating, citing disappointing fourth-quarter results and softer guidance for 2026. The medical technology company reported fourth-quarter revenue of $76 million, representing 12% year-over-year growth but falling well short of the Street’s $94 million expectation. The shortfall…